Ekso Bionics Valuation
| EKSO Stock | USD 0.50 0.05 11.11% |
Ekso Bionics is overvalued. Ekso Bionics Holdings shows a prevailing Real Value of $0.46 per share. The current price of the firm is $0.5. Our model computes the value of Ekso Bionics Holdings from reviewing the firm fundamentals such as Current Valuation of 11.16 M, profit margin of (0.63) %, and Shares Outstanding of 24.82 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Ekso Bionics' valuation include:
Price Book 0.9182 | Enterprise Value | Enterprise Value Ebitda 0.4628 | Price Sales 0.6925 | Enterprise Value Revenue 0.6225 |
Overvalued
Today
Please note that Ekso Bionics' price fluctuation is out of control at this time. Calculation of the real value of Ekso Bionics Holdings is based on 3 months time horizon. Increasing Ekso Bionics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ekso Bionics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ekso Stock. However, Ekso Bionics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.5 | Real 0.46 | Target 5.5 | Hype 0.5 | Naive 0.57 |
The intrinsic value of Ekso Bionics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ekso Bionics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ekso Bionics Holdings helps investors to forecast how Ekso stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ekso Bionics more accurately as focusing exclusively on Ekso Bionics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Ekso Bionics' intrinsic value based on its ongoing forecasts of Ekso Bionics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Ekso Bionics' closest peers.
Ekso Bionics Cash |
|
Ekso Valuation Trend
Knowing Ekso Bionics' actual value is paramount for traders when making sound investment determinations. Using both Ekso Bionics' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Ekso Bionics Total Value Analysis
Ekso Bionics Holdings is currently projected to have valuation of 11.16 M with market capitalization of 12.41 M, debt of 5.98 M, and cash on hands of 31.91 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Ekso Bionics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.16 M | 12.41 M | 5.98 M | 31.91 M |
Ekso Bionics Investor Information
About 16.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.92. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ekso Bionics Holdings recorded a loss per share of 0.56. The entity last dividend was issued on the 25th of March 2020. The firm had 1:15 split on the 25th of March 2020. Based on the key indicators related to Ekso Bionics' liquidity, profitability, solvency, and operating efficiency, Ekso Bionics Holdings is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Ekso Bionics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ekso Bionics has an asset utilization ratio of 67.26 percent. This suggests that the Company is making $0.67 for each dollar of assets. An increasing asset utilization means that Ekso Bionics Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Ekso Bionics Ownership Allocation
Ekso Bionics holds a total of 24.82 Million outstanding shares. Ekso Bionics Holdings shows 7.0 percent of its outstanding shares held by insiders and 16.3 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Ekso Bionics Profitability Analysis
The company reported the previous year's revenue of 17.93 M. Net Loss for the year was (11.33 M) with profit before overhead, payroll, taxes, and interest of 9.51 M.About Ekso Bionics Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Ekso Bionics Holdings. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Ekso Bionics Holdings based exclusively on its fundamental and basic technical indicators. By analyzing Ekso Bionics's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Ekso Bionics's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ekso Bionics. We calculate exposure to Ekso Bionics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ekso Bionics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 9.5 M | 5.5 M | |
| Pretax Profit Margin | (0.63) | (0.66) | |
| Operating Profit Margin | (0.58) | (0.61) | |
| Net Loss | (0.63) | (0.66) | |
| Gross Profit Margin | 0.53 | 0.30 |
Ekso Bionics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 20.2 M |
Ekso Bionics Current Valuation Indicators
Ekso Bionics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Ekso Bionics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Ekso Bionics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Ekso Bionics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Ekso Bionics' worth.When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.56) | Revenue Per Share | Quarterly Revenue Growth 0.05 | Return On Assets | Return On Equity |
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.